Effective as of the closing of the Merger, each of the former members of the board of directors of Xeris Pharmaceuticals, Inc., with the exception of Paul R. Edick, ceased to be directors of the Company and John Shannon, Steven M. Pieper and Beth Hecht were appointed to the board of directors of the Company.